Follicular growth and development under continuous gonadotropin-releasing hormone antagonist administration

Fertility and Sterility

Volumn 88, Issue 6, 2007, Pages 1677.e15-1677.e17

  Weissman, Ariel ^a   Ravhon, Amir ^a   Biran, Galia ^a   Levin, Dan ^a   Golan, Abraham ^a   Levran, David ^a  

^a WOLFSON MEDICAL CENTER   (Israel)

Author keywords

GnRH antagonists; ovarian effects; ovarian stimulation protocols

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN ANTAGONIST; GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE;

ADULT; ARTICLE; CASE REPORT; EMBRYO; ENDOCRINE FUNCTION; ENDOMETRIUM; ESTRADIOL BLOOD LEVEL; FEMALE; GONADOTROPIN BLOOD LEVEL; HUMAN; HUMAN CELL; HYPOPHYSIS; MALE INFERTILITY; MENSTRUATION; ORGAN GROWTH; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; OVULATION; PRIORITY JOURNAL; THICKNESS; ULTRASOUND; UNIVERSITY HOSPITAL;

EID: 36849090915     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.01.119     Document Type: Article

References (9)

1. Jenkins J.M., Anthony F.W., Wood P., Rushen D., Masson G.M., and Thomas E. The development of functional ovarian cysts during pituitary down-regulation. Hum Reprod 8 (1993) 1623-1627
2. Weissman A., Biran G., Ravhon A., Nahum H., Glezerman M., and Levran D. A randomized prospective study comparing the use of a standard GnRH antagonist versus a "long" antagonist protocol for controlled ovarian hyperstimulation prior to IVF. Fertil Steril 84 Suppl 1 (2005) S309 (abstract)
3. Barash A., Weissman A., Manor M., Milman D., Ben-Arie A., and Shoham Z. Prospective evaluation of endometrial thickness as a predictor of pituitary down-regulation after gonadotropin-releasing hormone analogue administration in an in vitro fertilization program. Fertil Steril 69 (1998) 496-499
4. Weissman A., Barash A., Shapiro H., and Casper R.F. Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadotrophin releasing hormone. Hum Reprod 13 (1998) 3421-3424
5. Almagor M., and Hovav Y. The development of an oocyte-containing follicle during gonadotrophin-releasing hormone agonist administration. Hum Reprod 16 (2001) 1698-1699
6. Ganirelix Dose-Finding Study Group. A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). Hum Reprod 13 (1998) 3023-3031
7. Al-Inany H., and Aboulghar M. GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod 17 (2002) 874-885
8. Ortmann O., Weiss J.M., and Diedrich K. Embryo implantation and GnRH antagonists: ovarian actions of GnRH antagonists. Hum Reprod 16 (2001) 608-611
9. Tarlatzis B.C., Fauser B.C., Kolibianakis E.M., Diedrich K., and Devroey P. GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update 12 (2006) 333-340